MX2016015568A - Derivados de nucleosidos para el tratamiento del cancer. - Google Patents

Derivados de nucleosidos para el tratamiento del cancer.

Info

Publication number
MX2016015568A
MX2016015568A MX2016015568A MX2016015568A MX2016015568A MX 2016015568 A MX2016015568 A MX 2016015568A MX 2016015568 A MX2016015568 A MX 2016015568A MX 2016015568 A MX2016015568 A MX 2016015568A MX 2016015568 A MX2016015568 A MX 2016015568A
Authority
MX
Mexico
Prior art keywords
cancer
treatment
nucleoside derivatives
compositions
compounds
Prior art date
Application number
MX2016015568A
Other languages
English (en)
Inventor
Jean-Laurent Paparin
Dousson Cyril
Dukhan David
René Alexandre François-
RAHALI Rachid
Claude Parsy Christophe
Original Assignee
Idenix Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idenix Pharmaceuticals Llc filed Critical Idenix Pharmaceuticals Llc
Priority claimed from PCT/IB2015/000957 external-priority patent/WO2015181624A2/en
Publication of MX2016015568A publication Critical patent/MX2016015568A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate

Abstract

Se proporcionan aquí compuestos, composiciones y métodos para el tratamiento de cáncer, incluyendo leucemia; en una modalidad, se describen compuestos y composiciones de derivados de nucleósidos, que pueden administrarse solos o en combinación con otros agentes anticancerígenos.
MX2016015568A 2014-05-28 2015-05-27 Derivados de nucleosidos para el tratamiento del cancer. MX2016015568A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462004066P 2014-05-28 2014-05-28
PCT/IB2015/000957 WO2015181624A2 (en) 2014-05-28 2015-05-27 Nucleoside derivatives for the treatment of cancer

Publications (1)

Publication Number Publication Date
MX2016015568A true MX2016015568A (es) 2017-07-04

Family

ID=58091942

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016015568A MX2016015568A (es) 2014-05-28 2015-05-27 Derivados de nucleosidos para el tratamiento del cancer.

Country Status (5)

Country Link
US (1) US20170101431A1 (es)
EP (1) EP3149017B1 (es)
CN (1) CN106459127A (es)
MX (1) MX2016015568A (es)
RU (1) RU2016149761A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3303361A1 (en) * 2015-05-27 2018-04-11 Idenix Pharmaceuticals LLC Nucleotides for the treatment of cancer
CN109651468A (zh) * 2018-12-20 2019-04-19 刘洪海 具有抑制病毒复制活性的核苷氨基磷酸酯类似物、制备方法及其药物用途
CN111068054B (zh) * 2019-11-06 2022-02-11 浙江大学医学院附属第一医院 以csf1r作为药物靶点治疗肿瘤的药剂及其制备方法
CN112409431B (zh) * 2020-12-07 2023-04-21 武汉伯瑞恒医药科技有限公司 阿糖胞苷结构类似物及其制备方法和用途
CN114349816A (zh) * 2021-11-30 2022-04-15 青岛博创生物科学研究院 一种基于氨肽酶n/cd13的小分子偶联分子及其制备方法和应用
WO2023201072A1 (en) * 2022-04-15 2023-10-19 Crestone, Inc. Novel 6-azauridine compounds as broad spectrum antiviral agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6023120B2 (ja) * 1979-08-13 1985-06-05 キッコーマン株式会社 アデノシン−３′，５′−環状リン酸アルキルトリエステルの製造法
WO1999045935A1 (en) * 1998-03-11 1999-09-16 Lipitek International, Inc. Novel nucleoside analogs and uses in treating disease
GB0505781D0 (en) * 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
US9156874B2 (en) * 2011-01-03 2015-10-13 Nanjing Molecular Research, Inc. Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs

Also Published As

Publication number Publication date
CN106459127A (zh) 2017-02-22
RU2016149761A (ru) 2018-07-02
US20170101431A1 (en) 2017-04-13
EP3149017A2 (en) 2017-04-05
RU2016149761A3 (es) 2019-01-25
EP3149017B1 (en) 2019-12-11

Similar Documents

Publication Publication Date Title
HK1249524A1 (zh) 用於治療血載癌症的免疫檢查點抑制劑
MA39906A (fr) Polythérapies pour le traitement du cancer
MY187540A (en) Compounds active towards bromodomains
JO3556B1 (ar) علاجات مدمجة لمعالجة السرطان
CL2015001985A1 (es) Compuestos de tiazolcarboxamidas y piridinacarboxamida, inhibidores de quinasa pim.
HK1256283A1 (zh) 治療癌症有用的二氫咪唑並吡嗪酮衍生物
ZA201807810B (en) Adenosine derivatives for use in the treatment of cancer
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
UY36075A (es) Derivados de tubulisina
MX2015011899A (es) Metodos para el tratamiento de cáncer y prevención de resistencia a los fármacos para el cáncer.
MX2016015568A (es) Derivados de nucleosidos para el tratamiento del cancer.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
WO2015181624A3 (en) Nucleoside derivatives for the treatment of cancer
MX2017002489A (es) Agentes terapeuticos humanos.
MX2019005349A (es) Uso de analogos de sangliferina macrociclicos como compuestos anticancerigenos.
PH12016501422A1 (en) Functionalised benzopyran compounds and use thereof
MX2017006026A (es) Apilimod para uso en el tratamiento de cancer colorrectal.
MY186475A (en) Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder
EP3413906A4 (en) COMBINATION COMPOSITIONS FOR CANCER TREATMENT, METHOD AND USES
WO2016130581A3 (en) Combination cancer therapy
MX2015013021A (es) 5-bromo-indirrubinas.
TW201713323A (en) Therapeutic compositions and methods of use thereof
PH12016501838A1 (en) Compounds and their methods of use
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions